Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Eur Arch Otorhinolaryngol ; 273(4): 933-8, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26100031

ABSTRACT

The aim of this study was to evaluate the histopathological impact, effectiveness, and safety of two hemostatic agents, Ankaferd Blood Stopper (ABS) and microporous polysaccharide hemospheres (MPH), in an experimental rabbit epistaxis model. Rabbits were randomly assigned, using a computerized random number generator, to the following three groups of six animals: group 1 (control, irrigated with saline); group 2 (ABS-treated); and group 3 (MPH-treated). In all groups, a standardized rabbit epistaxis model was used. Hemostasis time and extent of nasal bleeding were measured to compare the hemostatic effect of ABS and MPH among groups. Septums were removed for histopathological analysis, 7 days after the procedure. ABS reduced hemostasis time to 104.2 s and amount of bleeding to 20.5 mg. MPH reduced hemostasis time to 71.7 s and amount of bleeding to 11.5 mg. Mean bleeding time in wounds administered ABS and MPH was significantly shorter compared with wounds administered isotonic saline solution (p = 0.004). ABS and MPH application decreased bleeding significantly compared with the control group (p = 0.004). Bleeding time and amount in the MPH group was significantly reduced compared with the ABS group (p = 0.013 and p = 0.004, respectively). There was no significant difference in the histopathological evaluation results between the ABS, MPH, and control groups. Our data indicate that both ABS and MPH represent safe, effective, and fast-acting hemostatic agents in the management of epistaxis. MPH was more effective than ABS in terms of hemostasis time and amount of bleeding.


Subject(s)
Epistaxis , Plant Extracts/pharmacology , Polysaccharides/pharmacology , Administration, Topical , Animals , Bleeding Time/methods , Disease Models, Animal , Epistaxis/diagnosis , Epistaxis/drug therapy , Hemostatics/pharmacology , Rabbits , Treatment Outcome
2.
J Invest Surg ; 27(6): 319-26, 2014 Dec.
Article in English | MEDLINE | ID: mdl-24833552

ABSTRACT

OBJECTIVE: To evaluate intraperitoneal administration of Nigella sativa (NS) to prevent postoperative intraperitoneal adhesion (PPA) after surgical manipulation of rat uterine horn. MATERIALS AND METHODS: Two forms of NS were used in the study (Volatile oil (NSVO) and the ethanolic extract (NSEE)). A total of 50 rats were randomly assigned to the sham group (n = 10), control group (n = 10), NSVO group (n = 10), NSEE group (n = 10), and the Seprafilm group(n = 10). After 14 days, rats were sacrificed. Adhesions were examined macroscopically, and degree of adhesions was scored. A part of horn was excised, and superoxide dismutase (SOD) and glutathione peroxidase activities as well as malondialdehyde levels were evaluated, and histological score was calculated. RESULTS: Total microscopic score of the NSEE group was significantly lower than the control group (p = .001) and was marginally significantly lower than the seprafilm group (p = .005). Collagen formation score was higher in the seprafilm group compared to the sham and NSEE groups (p < 0.001, p = .003, respectively). Apoptotic cells were lower in the NSEE group compared to the control group (p = .003) and also lower in the NSEE and NSVO groups compared to the seprafilm group (p = .001, p < .001, respectively). Only SOD activity was higher in the NSVO and seprafilm groups compared to the control group (p < .001). CONCLUSION: NSEE form seems to have a possible effect in the prevention of PPAs. This may occur by its effect in decreasing collagen formation and by decreasing apoptosis in the injured tissues. NSVO form seems to induce SOD. Therefore, combined use of NSVO with seprafilm may increase the adhesion preventive effect of seprafilm.


Subject(s)
Abdomen/surgery , Nigella sativa , Plant Extracts/administration & dosage , Plant Extracts/therapeutic use , Plant Oils/administration & dosage , Plant Oils/therapeutic use , Tissue Adhesions/prevention & control , Animals , Collagen/metabolism , Female , Glutathione Peroxidase/metabolism , Hyaluronic Acid/therapeutic use , Injections, Intraperitoneal , Malondialdehyde/metabolism , Models, Animal , Postoperative Period , Rats , Rats, Wistar , Superoxide Dismutase/metabolism , Tissue Adhesions/metabolism , Treatment Outcome , Uterus/surgery
3.
Turk J Med Sci ; 44(3): 381-6, 2014.
Article in English | MEDLINE | ID: mdl-25558637

ABSTRACT

AIM: To evaluate the effects of montelukast and Hypericum perforatum against ischemia/reperfusion (I/R)-induced intestinal damage. MATERIALS AND METHODS: Twenty-eight hamsters were divided into 4 groups following midline abdominal laparotomy: control group (n = 7), I/R group (n = 7), montelukast and I/R (MIR) group (n = 7), and Hypericum perforatum and I/R (HPIR) group (n = 7). After 60 min of ischemia through obstruction of the superior mesenteric artery, 24 h of reperfusion was maintained. Ten minutes prior to the reperfusion period, the MIR group received 7 mg/kg of intraperitoneal montelukast and the HPIR group received 7 mg/kg of intraperitoneal Hypericum perforatum. Malondialdehyde, glutathione, myeloperoxidase, and cardiotrophin-1 levels were measured from blood samples. A semiquantitative histological evaluation was performed. RESULTS: Montelukast and Hypericum perforatum significantly reduced malondialdehyde levels and increased glutathione levels compared to the I/R group (P < 0.008). A statistically significant difference was also found between the I/R group and MIR and HPIR groups in terms of myelqperoxidase levels (P < 0.008). The MIR and HPIR groups showed increased cardiotrophin- 1 levels compared to the control and I/R groups (P < 0.008 for all). The MIR and HPIR groups showed significantly lower histological scores compared to the I/R group (P = 0.03 and P = 0.007, respectively). CONCLUSION: This study demonstrated the preventive effects of montelukast and Hypericum perforatum on I/R-induced intestinal injury.


Subject(s)
Acetates/pharmacology , Hypericum/chemistry , Intestines/blood supply , Plant Extracts/pharmacology , Protective Agents/pharmacology , Quinolines/pharmacology , Reperfusion Injury/drug therapy , Reperfusion Injury/prevention & control , Animals , Cricetinae , Cyclopropanes , Disease Models, Animal , Glutathione/blood , Intestines/drug effects , Malondialdehyde/blood , Mesenteric Artery, Superior/injuries , Mesocricetus , Random Allocation , Reperfusion Injury/blood , Sulfides
SELECTION OF CITATIONS
SEARCH DETAIL